Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAVWM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,445
Award facts
- Contract value 100% obligated
- $17,445.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a delivery order valued at $17,445.12 by the Defense Logistics Agency on July 30, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of July 31, 2025, with performance at the company's facility in Conshohocken, Pennsylvania. This delivery order was issued without a set-aside designation and represents one of numerous pharmaceutical supply contracts DMS Pharmaceutical Group has secured with the Defense Logistics Agency.
This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency through the SPE2DB program, a $499.999 billion vehicle valid through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's portfolio includes branded and generic prescription drugs, biologics, and medical consumables, positioning the company as a critical supplier within the federal pharmaceutical supply chain serving military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FAVWM?
SPE2DB25FAVWM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FAVWM worth?
The government has obligated $17,445 on SPE2DB25FAVWM.
Is contract SPE2DB25FAVWM an order under another contract?
Yes. SPE2DB25FAVWM is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVWM competed?
The extent of competition for SPE2DB25FAVWM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award